Ignite Creation Date:
2024-05-05 @ 4:46 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00319592
Status:
COMPLETED
Last Update Posted:
2012-08-20
First Post:
2006-04-28
Brief Title:
A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVaxTM-JE and JE-VAX
Sponsor:
Sanofi
Organization:
Sanofi
Study Overview
Official Title:
Randomized Double-blind Phase II Study of the Safety Tolerability and Immunogenicity Following Administration of Live Attenuated JE Vaccine ChimeriVax JE Compared With Mouse Brain-derived Inactivated JE Vaccine JE VAX
Status:
COMPLETED
Status Verified Date:
2012-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine non-inferiority in seroconversion and to compare the safety and tolerability between ChimeriVax-JE and JE-VAX to the respective homologous virus strain and several wild types strains after completion of vaccination course
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None